Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015
To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneum...
Gespeichert in:
Veröffentlicht in: | Medicine (Baltimore) 2019-05, Vol.98 (21), p.e15779-e15779 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e15779 |
---|---|
container_issue | 21 |
container_start_page | e15779 |
container_title | Medicine (Baltimore) |
container_volume | 98 |
creator | Pedraza-Serrano, Fernando Jiménez-García, Rodrigo López-de-Andrés, Ana Hernández-Barrera, Valentin Sánchez-Muñoz, Gema Puente-Maestu, Luis de-Miguel-Díez, Javier |
description | To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used. |
doi_str_mv | 10.1097/MD.0000000000015779 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6571208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2232125707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</originalsourceid><addsrcrecordid>eNpdkctuFDEQRa0IRIbAF0SKvGRBBz_b7Q0SmvCSErFIWFsVtzvtxNNubDcj-Ho8TBIe3pTkOvdWqS5Cx5ScUqLVm4uzU_LnUamUPkArKnnbSN2KJ2hFCJON0kocouc531aIKyaeoUNOKRNakRUK6xES2OKSz8XbjGHqcVyKjRuXcRzwDMW7qWQ8xjz7AsH_dD3e-jJiP1VZVRUPAYdlusG9zw5yFfoJX87gp9eYESpwibsqX6CnA4TsXt7XI_T1w_ur9afm_MvHz-t3540VkrQNkwMfOBMcWut6JTunKYWO2t5aIvWgO3kNLWNKKOqoJQ6IhE5rSTmnpO_5EXq7952X643rbd0_QTBz8htIP0wEb_7tTH40N_G7aaWijHTV4NW9QYrfFpeL2fhsXQgwubhkwxhnlElFVEX5HrUp5pzc8DiGErPLyVycmf9zqqqTvzd81DwEUwGxB7Yx7K58F5atS2Z0EMr4208qzZp6VU0kE6SpP6LlvwDApZ3Z</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232125707</pqid></control><display><type>article</type><title>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</title><source>Wolters Kluwer Open Health</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>IngentaConnect Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Pedraza-Serrano, Fernando ; Jiménez-García, Rodrigo ; López-de-Andrés, Ana ; Hernández-Barrera, Valentin ; Sánchez-Muñoz, Gema ; Puente-Maestu, Luis ; de-Miguel-Díez, Javier</creator><creatorcontrib>Pedraza-Serrano, Fernando ; Jiménez-García, Rodrigo ; López-de-Andrés, Ana ; Hernández-Barrera, Valentin ; Sánchez-Muñoz, Gema ; Puente-Maestu, Luis ; de-Miguel-Díez, Javier</creatorcontrib><description>To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000015779</identifier><identifier>PMID: 31124970</identifier><language>eng</language><publisher>United States: the Author(s). Published by Wolters Kluwer Health, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alveolitis, Extrinsic Allergic - diagnostic imaging ; Alveolitis, Extrinsic Allergic - epidemiology ; Child ; Comorbidity ; Cryptogenic Organizing Pneumonia - diagnostic imaging ; Cryptogenic Organizing Pneumonia - epidemiology ; Diabetes Mellitus - epidemiology ; Female ; Heart Failure - epidemiology ; Histiocytosis, Langerhans-Cell - diagnostic imaging ; Histiocytosis, Langerhans-Cell - epidemiology ; Hospital Mortality ; Hospitalization - statistics & numerical data ; Humans ; Idiopathic Pulmonary Fibrosis - diagnostic imaging ; Idiopathic Pulmonary Fibrosis - epidemiology ; Lung - diagnostic imaging ; Lung Diseases, Interstitial - diagnostic imaging ; Lung Diseases, Interstitial - epidemiology ; Male ; Middle Aged ; Observational Study ; Pulmonary Disease, Chronic Obstructive - epidemiology ; Retrospective Studies ; Sarcoidosis - diagnostic imaging ; Sarcoidosis - epidemiology ; Spain - epidemiology ; Tomography, X-Ray Computed - statistics & numerical data ; Young Adult</subject><ispartof>Medicine (Baltimore), 2019-05, Vol.98 (21), p.e15779-e15779</ispartof><rights>the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</citedby><cites>FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571208/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571208/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31124970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pedraza-Serrano, Fernando</creatorcontrib><creatorcontrib>Jiménez-García, Rodrigo</creatorcontrib><creatorcontrib>López-de-Andrés, Ana</creatorcontrib><creatorcontrib>Hernández-Barrera, Valentin</creatorcontrib><creatorcontrib>Sánchez-Muñoz, Gema</creatorcontrib><creatorcontrib>Puente-Maestu, Luis</creatorcontrib><creatorcontrib>de-Miguel-Díez, Javier</creatorcontrib><title>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alveolitis, Extrinsic Allergic - diagnostic imaging</subject><subject>Alveolitis, Extrinsic Allergic - epidemiology</subject><subject>Child</subject><subject>Comorbidity</subject><subject>Cryptogenic Organizing Pneumonia - diagnostic imaging</subject><subject>Cryptogenic Organizing Pneumonia - epidemiology</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Female</subject><subject>Heart Failure - epidemiology</subject><subject>Histiocytosis, Langerhans-Cell - diagnostic imaging</subject><subject>Histiocytosis, Langerhans-Cell - epidemiology</subject><subject>Hospital Mortality</subject><subject>Hospitalization - statistics & numerical data</subject><subject>Humans</subject><subject>Idiopathic Pulmonary Fibrosis - diagnostic imaging</subject><subject>Idiopathic Pulmonary Fibrosis - epidemiology</subject><subject>Lung - diagnostic imaging</subject><subject>Lung Diseases, Interstitial - diagnostic imaging</subject><subject>Lung Diseases, Interstitial - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Observational Study</subject><subject>Pulmonary Disease, Chronic Obstructive - epidemiology</subject><subject>Retrospective Studies</subject><subject>Sarcoidosis - diagnostic imaging</subject><subject>Sarcoidosis - epidemiology</subject><subject>Spain - epidemiology</subject><subject>Tomography, X-Ray Computed - statistics & numerical data</subject><subject>Young Adult</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctuFDEQRa0IRIbAF0SKvGRBBz_b7Q0SmvCSErFIWFsVtzvtxNNubDcj-Ho8TBIe3pTkOvdWqS5Cx5ScUqLVm4uzU_LnUamUPkArKnnbSN2KJ2hFCJON0kocouc531aIKyaeoUNOKRNakRUK6xES2OKSz8XbjGHqcVyKjRuXcRzwDMW7qWQ8xjz7AsH_dD3e-jJiP1VZVRUPAYdlusG9zw5yFfoJX87gp9eYESpwibsqX6CnA4TsXt7XI_T1w_ur9afm_MvHz-t3540VkrQNkwMfOBMcWut6JTunKYWO2t5aIvWgO3kNLWNKKOqoJQ6IhE5rSTmnpO_5EXq7952X643rbd0_QTBz8htIP0wEb_7tTH40N_G7aaWijHTV4NW9QYrfFpeL2fhsXQgwubhkwxhnlElFVEX5HrUp5pzc8DiGErPLyVycmf9zqqqTvzd81DwEUwGxB7Yx7K58F5atS2Z0EMr4208qzZp6VU0kE6SpP6LlvwDApZ3Z</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Pedraza-Serrano, Fernando</creator><creator>Jiménez-García, Rodrigo</creator><creator>López-de-Andrés, Ana</creator><creator>Hernández-Barrera, Valentin</creator><creator>Sánchez-Muñoz, Gema</creator><creator>Puente-Maestu, Luis</creator><creator>de-Miguel-Díez, Javier</creator><general>the Author(s). Published by Wolters Kluwer Health, Inc</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190501</creationdate><title>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</title><author>Pedraza-Serrano, Fernando ; Jiménez-García, Rodrigo ; López-de-Andrés, Ana ; Hernández-Barrera, Valentin ; Sánchez-Muñoz, Gema ; Puente-Maestu, Luis ; de-Miguel-Díez, Javier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alveolitis, Extrinsic Allergic - diagnostic imaging</topic><topic>Alveolitis, Extrinsic Allergic - epidemiology</topic><topic>Child</topic><topic>Comorbidity</topic><topic>Cryptogenic Organizing Pneumonia - diagnostic imaging</topic><topic>Cryptogenic Organizing Pneumonia - epidemiology</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Female</topic><topic>Heart Failure - epidemiology</topic><topic>Histiocytosis, Langerhans-Cell - diagnostic imaging</topic><topic>Histiocytosis, Langerhans-Cell - epidemiology</topic><topic>Hospital Mortality</topic><topic>Hospitalization - statistics & numerical data</topic><topic>Humans</topic><topic>Idiopathic Pulmonary Fibrosis - diagnostic imaging</topic><topic>Idiopathic Pulmonary Fibrosis - epidemiology</topic><topic>Lung - diagnostic imaging</topic><topic>Lung Diseases, Interstitial - diagnostic imaging</topic><topic>Lung Diseases, Interstitial - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Observational Study</topic><topic>Pulmonary Disease, Chronic Obstructive - epidemiology</topic><topic>Retrospective Studies</topic><topic>Sarcoidosis - diagnostic imaging</topic><topic>Sarcoidosis - epidemiology</topic><topic>Spain - epidemiology</topic><topic>Tomography, X-Ray Computed - statistics & numerical data</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pedraza-Serrano, Fernando</creatorcontrib><creatorcontrib>Jiménez-García, Rodrigo</creatorcontrib><creatorcontrib>López-de-Andrés, Ana</creatorcontrib><creatorcontrib>Hernández-Barrera, Valentin</creatorcontrib><creatorcontrib>Sánchez-Muñoz, Gema</creatorcontrib><creatorcontrib>Puente-Maestu, Luis</creatorcontrib><creatorcontrib>de-Miguel-Díez, Javier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pedraza-Serrano, Fernando</au><au>Jiménez-García, Rodrigo</au><au>López-de-Andrés, Ana</au><au>Hernández-Barrera, Valentin</au><au>Sánchez-Muñoz, Gema</au><au>Puente-Maestu, Luis</au><au>de-Miguel-Díez, Javier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>98</volume><issue>21</issue><spage>e15779</spage><epage>e15779</epage><pages>e15779-e15779</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used.</abstract><cop>United States</cop><pub>the Author(s). Published by Wolters Kluwer Health, Inc</pub><pmid>31124970</pmid><doi>10.1097/MD.0000000000015779</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2019-05, Vol.98 (21), p.e15779-e15779 |
issn | 0025-7974 1536-5964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6571208 |
source | Wolters Kluwer Open Health; MEDLINE; DOAJ Directory of Open Access Journals; IngentaConnect Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adolescent Adult Aged Aged, 80 and over Alveolitis, Extrinsic Allergic - diagnostic imaging Alveolitis, Extrinsic Allergic - epidemiology Child Comorbidity Cryptogenic Organizing Pneumonia - diagnostic imaging Cryptogenic Organizing Pneumonia - epidemiology Diabetes Mellitus - epidemiology Female Heart Failure - epidemiology Histiocytosis, Langerhans-Cell - diagnostic imaging Histiocytosis, Langerhans-Cell - epidemiology Hospital Mortality Hospitalization - statistics & numerical data Humans Idiopathic Pulmonary Fibrosis - diagnostic imaging Idiopathic Pulmonary Fibrosis - epidemiology Lung - diagnostic imaging Lung Diseases, Interstitial - diagnostic imaging Lung Diseases, Interstitial - epidemiology Male Middle Aged Observational Study Pulmonary Disease, Chronic Obstructive - epidemiology Retrospective Studies Sarcoidosis - diagnostic imaging Sarcoidosis - epidemiology Spain - epidemiology Tomography, X-Ray Computed - statistics & numerical data Young Adult |
title | Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T14%3A21%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20outcomes%20of%20patients%20hospitalized%20with%20interstitial%20lung%20diseases%20in%20Spain,%202014%20to%202015&rft.jtitle=Medicine%20(Baltimore)&rft.au=Pedraza-Serrano,%20Fernando&rft.date=2019-05-01&rft.volume=98&rft.issue=21&rft.spage=e15779&rft.epage=e15779&rft.pages=e15779-e15779&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000015779&rft_dat=%3Cproquest_pubme%3E2232125707%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2232125707&rft_id=info:pmid/31124970&rfr_iscdi=true |